Chemical Drug Delivery System

Chemical delivery system (CDS) is customized by concede unambiguous enzymes solely on the desired site to induce drug action. Formerly, the hypothesis of CDS was used in many pharmaceutical applications with reference to the targeted sites, viz brain, eyes, and other organs in the body. Simplest way to reduce drug toxic behavior is to create metabolic stable drugs. At first peek, this initiative seems very simple, because to evade toxicity, easiest way is avoiding the metabolism of the drug and following a simple pharmacokinetic method for drugs controlled by renal excretion. The metabolic and toxicological properties of these molecules need to be taken into account during drug development. Metabolism of foreign substances by enzymes within the body leads to the formation of toxic or non-toxic metabolites. The use of chemicals in the distribution of drugs is not only beneficial but can also be dangerous due to their toxicity and other inconsistencies. The CDDS approach, such as the use of polymers, has a unique advantage in drug delivery applications and allows improving clinical and therapeutic outcomes in the design of new drug delivery systems. When designing distribution systems, care should be taken to select the correct polymer. The crucial objective is to realize cost-effective, biocompatible, and multifunctional, low-toxicity polymers that will help deliver products to various stages of clinical trials and help humans.